retatrutide development status eli lilly fda approval Prepares for Filing Following Additional Phase 3 Data in Diabetes, CVD Lilly shares safety, tolerability data

Variable timing creates fluctuating drug concentrations that can feel like inconsistent effectiveness

How to Talk to Your Doctor About GLP-1 Weight Loss Drugs Chronic Diseases That GLP-1s Are FDA-Approved to Treat GLP-1s for Heart Disease In March 2024, the FDA approved the GLP-1 drug Wegovy (semaglutide) to treat heart disease in people who are overweight or who have obesity the first approval for a GLP-1 medication outside of diabetes or weight loss

TB-500 Effects on Sperm Motility and Morphology TB-500 produces notable improvements in sperm motility parameters through its actions on actin regulation and cellular repair mechanisms

PMID: 28323117

Complete timeline of the events is shown in Supplementary Figure 1